Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography

Analytical and Bioanalytical Chemistry

Volumn 404, Issue 1, 2012, Pages 217-228

  Lin, Shu Chiao ^a,b   Liu, Hsiang Yin ^a   Lin, Shu Wen ^a,b   Yao, Ming ^b   Wu, Un In ^b   Kuo, Hsiu Po ^c   Kuo, Ching Hua ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

High salt stacking; Itraconazole; Posaconazole; Sweeping MEKC; Therapeutic drug Monitoring; Voriconazole

Indexed keywords

HIGH SALT STACKING; ITRACONAZOLE; POSACONAZOLE; SWEEPING-MEKC; THERAPEUTIC DRUG MONITORING; VORICONAZOLE;

ACETONITRILE; BIOSENSORS; ELECTROLYTES; LIQUID CHROMATOGRAPHY; NITROGEN COMPOUNDS; PATIENT MONITORING; PHOSPHORIC ACID; SODIUM SULFATE; TISSUE;

DRUG PRODUCTS;

ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; BLOOD; EVALUATION; HUMAN; METHODOLOGY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; MYCOSIS;

ANTIFUNGAL AGENTS; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; HUMANS; MYCOSES; TRIAZOLES;

EID: 84865594766     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6087-3     Document Type: Article

References (50)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34(7):909-917 (Pubitemid 34229758)
2. Goodwin ML, Drew RH (2008) Antifungal serum concentration monitoring: an update. J Antimicrob Chemother 61(1):17-25
3. Andes D, Pascual A, Marchetti O (2009) Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother 53(1):24-34
4. Cartledge JD, Midgely J, Gazzard BG (1997) Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. J Clin Pathol 50(6):477-480 (Pubitemid 27315993)
5. Stevens DA (1999) Itraconazole in cyclodextrin solution. Pharmacotherapy 19(5):603-611 (Pubitemid 29211805)
6. Jaruratanasirikul S, Kleepkaew A (1997) Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 52(3):235-237 (Pubitemid 27278380)
7. Vanpeer A,Woestenborghs R, Heykants J, Gasparini R, Gauwenbergh G (1989) The effects of food and dose on the oral systemic availability of itraconazole in healthy-subjects. Eur J Clin Pharmacol 36(4):423-426 (Pubitemid 19140050)
8. Johnson LB, Kauffman CA (2003) Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36(5):630-637 (Pubitemid 36259570)
9. Desta Z, Zhao XJ, Shin JG, Flockhart DA (2002) Clinical significance of the cytochrome P4502C19 genetic polymorphism. Clin Pharmacokinet 41(12):913-958 (Pubitemid 35168437)
10. Ullmann AJ, Cornely OA, Burchardt A, Hachem R, Kontoyiannis DP, Topelt K, Courtney R, Wexler D, Krishna G, Martinho M, Corcoran G, Raad I (2006) Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 50 (2):658-666 (Pubitemid 43190980)
11. Lewis R, Hogan H, Howell A, Safdar A (2008) Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection. Leuk Lymphoma 49(1):163-165 (Pubitemid 351146899)
12. Krishna G, Moton A, Ma L, Medlock MM, McLeod J (2009) Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrob Agents Chemother 53(3):958-966
13. Ekiert RJ, Krzek J, Talik P (2010) Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents - a review. Talanta 82(4):1090-1100
14. Srivatsan V, Dasgupta AK, Kale P, Datla RR, Soni D, Patel M, Patel R, Mavadhiya C (2004) Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography. J Chromatogr A 1031(1-2):307-313 (Pubitemid 38264248)
15. Khoschsorur G, Fruehwirth F, Zelzer S (2005) Isocratic highperformance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum. Antimicrob Agents Chemother 49(8):3569-3571 (Pubitemid 41060622)
16. Pennick GJ, Clark M, Sutton DA, Rinaldi MG (2003) Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob Agents Chemother 47(7):2348-2350 (Pubitemid 36753600)
17. Chhun S, Rey E, Tran A, Lortholary O, Pons G, Jullien V (2007) Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B 852(1-2):223-228 (Pubitemid 46839210)
18. Neubauer W, Konig A, Bolek R, Trittler R, Engelhardt M, Jung M, Kummerer K (2009) Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching technique. J Chromatogr B 877(24):2493-2498
19. Vogeser M, Spohrer U, Schiel X (2003) Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solidphase extraction. Clin Chem Lab Med 41(7):915-920 (Pubitemid 37010185)
20. Kousoulos C, Tsatsou G, Apostolou C, Dotsikas Y, Loukas YL (2006) Development of a high-throughput method for the determination of itraconazole and its hydroxy metabolite in human plasma, employing automated liquid-liquid extraction based on 96- well format plates and LC/MS/MS. Anal Bioanal Chem 384 (1):199-207 (Pubitemid 41817858)
21. Bharathi DV, Hotha KK, Sagar PVV, Kumar SS, Reddy PR, Naidu A, Mullangi R (2008) Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: application to a bioequivalence study. J Chromatogr B 868(1-2):70-76
22. Keevil BG, Newman S, Lockhart S, Howard SJ, Moore CB, Denning DW (2004) Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther Drug Monit 26(6):650-657 (Pubitemid 39579147)
23. Egle H, Trittler R, Konig A, Kummerer K (2005) Fast, fully automated analysis of voriconazole from serum by LC-LC-ESIMS- MS with parallel column-switching technique. J Chromatogr B 814(2):361-367 (Pubitemid 40091656)
24. Cunliffe JM, Noren CF, Hayes RN, Clement RP, Shen JX (2009) A high-throughput LC-MS/MS method for the quantitation of posaconazole in human plasma: implementing fused core silica liquid chromatography. J Pharm Biomed Anal 50(1):46-52
25. Shen JX, Krishna G, Hayes RN (2007) A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma. J Pharm Biomed Anal 43(1):228-236 (Pubitemid 44856187)
26. Verdier MC, Bentue-Ferrer D, Tribut O, Bellissant E (2010) Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma. Clin Chem Lab Med 48(10):1515-1522
27. Alffenaar JWC, Wessels AMA, van Hateren K, Greijdanus B, Kosterink JGW, Uges DRA (2010) Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS. J Chromatogr B 878(1):39-44
28. Beste KY, Burkhardt O, Kaever V (2012) Rapid HPLC-MS/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma. Clin ChimActa 413(1-2):240-245
29. Pauwels S, Vermeersch P, Van Eldere J, Desmet K (2012) Fast and simple LC-MS/MS method for quantifying plasma voriconazole. Clin Chim Acta 413(7-8):740-743
30. Breadmore MC, Prochazkova A, Theurillat R, Thormann W (2003) Determination of itraconazole and hydroxyitraconazole in human serum and plasma by micellar electrokinetic chromatography. J Chromatogr A 1014(1-2):57-70 (Pubitemid 37311158)
31. Breadmore MC, Thormann W (2003) Capillary electrophoresis evidence for the stereoselective metabolism of itraconazole in man. Electrophoresis 24(15):2588-2597 (Pubitemid 38089046)
32. Lin SC, Lin SW, Chen JM, Kuo CH (2010) Using sweepingmicellar electrokinetic chromatography to determine voriconazole in patient plasma. Talanta 82(2):653-659
33. Liao HW, Lin SW, Wu UI, Kuo CH (2012) Rapid and sensitive determination of posaconazole in patient plasma by capillary electrophoresis with field-amplified sample stacking. J Chromatogr A 1226:48-54
34. Theurillat R, Zimmerli S, Thormann W (2010) Determination of voriconazole in human serum and plasma by micellar electrokinetic chromatography. J Pharm Biomed Anal 53(5):1313-1318
35. Gordien JB, Pigneux A, Vigouroux S, Tabrizi R, Accoceberry I, Bernadou JM, Rouault A, Saux MC, Breilh D (2009) Simultaneous determination of five systemic azoles in plasma by highperformance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 50(5):932-938
36. Crego AL, Marina ML, Lavandera JL (2001) Optimization of the separation of a group of antifungals by capillary zone electrophoresis. J Chromatogr A 917(1-2):337-345 (Pubitemid 32391336)
37. Crego AL, Gomez J, Marina ML, Lavandera JL (2001) Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals. Electrophoresis 22 (12):2503-2511 (Pubitemid 32725557)
38. Quirino JP, Terabe S (1998) Exceeding 5000-fold concentration of dilute analytes in micellar electrokinetic chromatography. Science 282(5388):465-468 (Pubitemid 28483671)
39. Quirino JP, Kim JB, Terabe S (2002) Sweeping: concentration mechanism and applications to high-sensitivity analysis in capillary electrophoresis. J Chromatogr A 965(1-2):357-373 (Pubitemid 34876326)
40. Palmer J, Munro NJ, Landers JP (1999) A universal concept for stacking neutral analytes in micellar capillary electrophoresis. Anal Chem 71(9):1679-1687 (Pubitemid 29222158)
41. Giordano BC, Newman CID, Federowicz PM, Collins GE, Burgi DS (2007) Micelle stacking in micellar electrokinetic chromatography. Anal Chem 79(16):6287-6294 (Pubitemid 47282342)
42. Micromedex® Healthcare Series (2012) ThomsonReuters (Healthcare) Inc, Greenwood Village, CO. http://www.thomsonhc.com. Accessed 08 Mar 2012
43. Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M (2004) Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 57(2):218-222 (Pubitemid 38223535)
44. Buchanan CM, Buchanan NL, Edgar KJ, Ramsey MG (2007) Solubilty and dissolution studies of antifungal drug: hydroxybutenylbeta- cyclodextrin complexes. Cellulose 14(1):35-47 (Pubitemid 46486879)
45. Tsai IL, Sun SW, Liao HW, Lin SC, Kuo CH (2009) Rapid analysis of melamine in infant formula by sweeping-micellar electrokinetic chromatography. J Chromatogr A 1216(47):8296-8303
46. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE (2007) Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 51 (1):239-244 (Pubitemid 46047712)
47. Chen N, Terabe S, Nakagawa T (1995) Effect of organic modifier concentrations on electrokinetic migrations in micellar electrokinetic chromatography. Electrophoresis 16(8):1457-1462
48. Kuo CH, Lee SS, Chang HY, Sun SW (2003) Analysis of lignans using micellar electrokinetic chromatography. Electrophoresis 24 (6):1047-1053, 14(1):35-47
49. Thompson GR, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS (2009) Posaconazole therapeutic drug monitoring: a reference laboratory experience. Antimicrob Agents Chemother 53(5):2223-222447
50. Ueda K, Nannya Y, Kumano K, Hangaishi A, Takahashi T, Imai Y, Kurokawa M (2009) Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. Int J Hematol 89(5):592-599